Ana María Rivas Estilla

Prof. Dr. Ana María Rivas Estilla


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
AEAna María Rivas Estilla
Ana María Rivas Estilla
NMNatalia Martinez-Acuña
Natalia Martinez-Acuña
DADaniel Arellanos-Soto
Daniel Arellanos-Soto
KGKame Galan-Huerta
Kame Galan-Huerta
SSSonia Lozano Sepulveda
Sonia Lozano Sepulveda
ARAna M. Rivas-Estilla
Ana M. Rivas-Estilla
The new coronavirus that was first identified in December 2019 in Wuhan China, now called SARS-CoV-2, which causes the disease called COVID-19, has spread from China to the entire world in a few months. Due to its contagious potential (R0: 5.7) and because there is still no effective treatment to stop the infection, and a vaccine for prevention it is not yet available to the general population, COVID-19 is currently considered a global health problem. The need to implement sensitive methods for the identification of individuals with COVID-19 has led to the development of different molecular and immunological tests. The importance of a timely and accurate diagnosis is essential to determine the course of the pandemic. The interpretation of the results obtained by each test as well as the factors that affect these results have not been fully described. In this review, we describe and analyze the different SARS-CoV-2 detection methods that have been performed in Mexico and are available worldwide, outlining their strengths and weaknesses. Further, a broader perspective of the correct use and interpretation of the results obtained with these diagnostic tools is proposed to improve the containment strategy and identify the true impact of the pandemic.